138 related articles for article (PubMed ID: 2050852)
1. Improvement of scleromyxedema associated with isotretinoin therapy.
Hisler BM; Savoy LB; Hashimoto K
J Am Acad Dermatol; 1991 May; 24(5 Pt 2):854-7. PubMed ID: 2050852
[TBL] [Abstract][Full Text] [Related]
2. Scleromyxedema: therapeutic response to isotretinoin in three patients.
Milam CP; Cohen LE; Fenske NA; Ling NS
J Am Acad Dermatol; 1988 Sep; 19(3):469-77. PubMed ID: 3170809
[TBL] [Abstract][Full Text] [Related]
3. [Scleromyxedema therapy with isotretinoin].
Lominska-Lasota K; Rosen-Uzelac G; Reichl W; Bauer R
Z Hautkr; 1988 Feb; 63(2):137-8, 141. PubMed ID: 3163867
[TBL] [Abstract][Full Text] [Related]
4. Scleromyxedema: An experience using treatment with systemic corticosteroid and review of the published work.
Lin YC; Wang HC; Shen JL
J Dermatol; 2006 Mar; 33(3):207-10. PubMed ID: 16620228
[TBL] [Abstract][Full Text] [Related]
5. Scleromyxedema.
Chanda JJ
Cutis; 1979 Nov; 24(5):549-52. PubMed ID: 520033
[TBL] [Abstract][Full Text] [Related]
6. [Initial scleromyxedema. Successful treatment with melphalan].
Schubert K; Stein A; Meurer M
Hautarzt; 2002 Jul; 53(7):478-82. PubMed ID: 12219271
[TBL] [Abstract][Full Text] [Related]
7. Thalidomide as a potential treatment for scleromyxedema.
Caradonna S; Jacobe H
Arch Dermatol; 2004 Mar; 140(3):277-80. PubMed ID: 15023770
[No Abstract] [Full Text] [Related]
8. Tumorous variant of scleromyxedema. Successful therapy with intravenous immunoglobulins.
Wojas-Pelc A; Błaszczyk M; Glińska M; Jabłońska S
J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):462-5. PubMed ID: 15987294
[TBL] [Abstract][Full Text] [Related]
9. Two cases of scleromyxedema.
Jepsen LV
Acta Derm Venereol; 1980; 60(1):77-79. PubMed ID: 6153843
[TBL] [Abstract][Full Text] [Related]
10. Treatment of solitary keratoacanthomas with oral isotretinoin.
Goldberg LH; Rosen T; Becker J; Knauss A
J Am Acad Dermatol; 1990 Nov; 23(5 Pt 1):934-6. PubMed ID: 2254482
[No Abstract] [Full Text] [Related]
11. Isotretinoin for the treatment of sebaceous hyperplasia.
Grekin RC; Ellis CN
Cutis; 1984 Jul; 34(1):90-2. PubMed ID: 6590206
[TBL] [Abstract][Full Text] [Related]
12. O'Brien's actinic granuloma: response to isotretinoin.
Ratnavel RC; Grant JW; Handfield-Jones SE; Norris PG
J R Soc Med; 1995 Sep; 88(9):528P-529P. PubMed ID: 7562853
[TBL] [Abstract][Full Text] [Related]
13. Scleromyxedema associated with arthritis and myopathy: a case report.
Espinosa A; De Miguel E; Morales C; Fonseca E; Gijón-Baños J
Clin Exp Rheumatol; 1993; 11(5):545-7. PubMed ID: 8275591
[TBL] [Abstract][Full Text] [Related]
14. Steatocystoma multiplex treated with isotretinoin: a delayed response.
Moritz DL; Silverman RA
Cutis; 1988 Nov; 42(5):437-9. PubMed ID: 3197445
[TBL] [Abstract][Full Text] [Related]
15. Scleromyxedema. A dramatic response to melphalan.
Feldman P; Shapiro L; Pick AI; Slatkin MH
Arch Dermatol; 1969 Jan; 99(1):51-6. PubMed ID: 4178219
[No Abstract] [Full Text] [Related]
16. PUVA treatment of scleromyxoedema.
Farr PM; Ive FA
Br J Dermatol; 1984 Mar; 110(3):347-50. PubMed ID: 6696849
[TBL] [Abstract][Full Text] [Related]
17. [Scleromyxedema associated with myopathy].
Catalá J; López-Aldeguer J; Vílchez JJ; Chirivella M; Catalá MT
Rev Clin Esp; 1993 Jul; 193(3):119-21. PubMed ID: 8356289
[TBL] [Abstract][Full Text] [Related]
18. A case of atrophoderma vermiculatum responding to isotretinoin.
Weightman W
Clin Exp Dermatol; 1998 Mar; 23(2):89-91. PubMed ID: 9692315
[TBL] [Abstract][Full Text] [Related]
19. Scleromyxedema: a complete response to prednisone.
Rayson D; Lust JA; Duncan A; Su WP
Mayo Clin Proc; 1999 May; 74(5):481-4. PubMed ID: 10319080
[TBL] [Abstract][Full Text] [Related]
20. Scleromyxedema is a scleroderma-like disorder and not a coexistance of scleroderma with papular mucinosis.
Jablonska S; Blaszczyk M
Eur J Dermatol; 1999; 9(7):551-4. PubMed ID: 10523735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
